TrialCritical care (London, England)2022

Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trial.

Gael B Morrow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.